TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Area Under the Plasma Concentration- Time Curve (AUC) From Time 0 to the Time of the Last Measurable Concentration of ABBV-623
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of ABBV-992
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Size of white spot lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Lymphocyte T CD4+ cells since baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in T helper1 (Th1) Lymphocyte T CD4+ cells since baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Lymphocyte T CD8+ cells since baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: number of patients who undergo hysterectomy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of qualifying treatment emergent adverse events or dose limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: onset of tinnitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Dose-limiting Toxicities (DLTs) (monotherapy only)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Dose-limiting Toxicities (DLTs) (combination therapy only)
Endpoint domain: Adverse events/effects
Primary endpoint: Pure Pathological Response (PPR) Rate for SM in Selective KIT Inhibitor-naïve Participants (monotherapy only)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Electromyography muscle activity of the masseter and temporalis muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Time from recruitment to cessation of clinical illness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time from recruitment to cessation of viral shedding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Acylated ghrelin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total ghrelin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in total corneal fluorescein staining (tCFS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change in eye dryness score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Number of Participants with Echelon Contour Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of compliant patients to the proposed diet
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Agreement between Senseye OBCI measures and gold-standard measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of the Senseye tool
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Test-retest for repeatability of the Senseye tool
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in pH in arterial blood gas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in PaCO2 in arterial blood gas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in lactate in arterial blood gas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in bicarbonate in arterial blood gas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adapted intervention acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CAT (Average)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: CEJ to base of defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CEJ to alveolar crest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: King's Health Questionnaire (KHQ)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incontinence Quality of Life Questionnaire (I-QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants testing for the first time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of newly diagnosed HIV-infected or known positive and not in care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Linking a new positive or known positive not in care to a treatment center
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Initiating ART, or re-initiating ART if previously lost to follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative changes in teeth sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between VisionCheck and phoropter refraction measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total variability and variance components for repeatability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of symptomatic COVID-19 cases
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Adverse Events (AEs) for Single- dose Cohort
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with AEs for Multiple- dose Cohort
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma Concentration of JNJ-67953964 for Single- dose Cohort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Concentration of JNJ-67953964 for Multiple- dose Cohort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Treatment-Emergent Adverse Events at 3 months
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Treatment-Emergent Adverse Events at 12 months
Endpoint domain: Adverse events/effects
Primary endpoint: Change in mean interstitial glucose level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in the ALSFRS-R total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined assessment of the function and survival (CAFS) score
Endpoint domain: Mortality/survival
Primary endpoint: Rate of total flap loss
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of partial flap loss
Endpoint domain: Adverse events/effects
Primary endpoint: Variation of Breastfeeding status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Electrical Activity of the Diaphragm (Edi minimum)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Response Rate at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-socket interface pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement on the knowledge of cesarean section procedures
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: improvement on the self-confidence of cesarean section procedures
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ronald Morris Disability (RMD) questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Quality of Recovery 15 Survey
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Drink retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electrolyte balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Speed of rehydration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delirium evaluation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Successful removal of skin tag
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Speech function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glucocorticoid-induced hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Glucocorticoid-induced diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glucocorticoid-induced osteoporosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: post-DDAVP FVIII peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: post-DDAVP FVIII recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: post-DDAVP FVIII clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: post-DDAVP FVIII area under the curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: post-DDAVP duration with FVIII normalized above 0.5 IU.dL-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Frequency of 'naive' patients with CCS undergoing elective PCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of complex coronary intervention in patients undergoing elective PCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of Participants with Confirmed Objective Response Rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Diagnosis rate of early gastrointestinal cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Weight loss follow up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adherence to the intervention arms
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Retention for follow-up measurements
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Changes in corneal topography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline on the Disease Activity Score (DAS28-hsCRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiology outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical outcome, self-administered questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical outcome, by surgeon's evaluating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Childbirth experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time in Range 70-180 mg/dL (TIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: acute post-op pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Tear film breakup time (TFBUT) at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Tear film breakup time (TFBUT) at 15 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RPE Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Rate of mesopancreatic infiltration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety levels measured by STAI XT-1
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Fatigue State Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Pharmacokinetic profile of rifabutin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Human Perception Assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline pregnancy-related low back Pain at 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from Baseline Function at 4 weeks
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Evaluation of current state of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Evaluation of anxiety proneness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Evaluation of uncertainty and perceptions of effective decision-making
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Quality of life measure with EuroQol-5D-5L
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in discapacity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Physical Activity Levels measured with IPAQ
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Respiratory Exchange Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in maximum expiratory pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Disease Activity Score in 28 Joints (DAS28)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean RANKL level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean OPG level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Fugl Meyer (lower extremity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stroke specific quality of life (SS-QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: significant relapse
Endpoint domain: Adverse events/effects
Primary endpoint: Erectile dysfunction severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of body movements or coughing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fahn-Tolosa-Marin Clinical Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Oxygen Reserve Index Value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of VX-103
Endpoint domain: Adverse events/effects
Primary endpoint: Composition of intestinal, peritoneal and uterine microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in fatigue levels based on FACIT Fatigue Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Incidence of abnormalities in clinical laboratory assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability of participants to remain on their assigned dose for the full 30 day treatment period
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of Grade II-IV acute GVHD at Day 100
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of respiratory tract infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Tumor drug uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of subjects with CTCAE 5.0 or DAIDS grade 3 or higher adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: incidence rate of 5-point MACE
Endpoint domain: Mortality/survival
Primary endpoint: Rate of ESD-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Area Under the Plasma Analyte Concentration Time Curve (AUC [0-Last])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration Time Curve (AUC [0-Infinity])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Desired insertion depth of ES thermistor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freiburger monosyllabic word recognition score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Health-related quality of life scale (EuroQol-5D)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: The World Health Organization Quality of Life-Old (WHOQOL-OLD Scale)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: The Generalized Anxiety Disorder Questionnaire-2 (GAD-2)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: The Patient Health Questionnaire-2 (PHQ-2)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Endometriosis Health Profile-30 Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cepstral Peak Prominence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The difference between the first and second harmonic (H1-H2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average closing velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in algometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EMG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle synergies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intubation condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time from SAB to Bromage score of I
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12 month viral suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients deceased without progression
Endpoint domain: Mortality/survival
Primary endpoint: Change in body lean mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of colonies forming units of bacterial cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Oxygen consumption in response to acute psychological stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate in response to acute psychological stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Additional heart rate in response to acute psychological stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to clinical success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiopulmonary Resuscitation (CPR) Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Resting Motor Threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Manganese uptake rate in left ventricular wall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Bone changes around the femoral implant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent syllables stuttered (%SS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity rating (SR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of positive results using IGRA and TST
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pure tone average with air and bone conduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ECAPs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ECochG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in muscle mass using Dual X-ray Absorptiometry (DXA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in muscle mass using Computed Tomography (CT) scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in peak isokinetic strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of diffusion sequences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to correct CVC position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Work Ability Single Item Scale (WAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Work Ability physical demands
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Work Ability mental demands
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: NRS-Pain score at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants achieving DLQI score 0 or 1
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Postoperative Recovery Index (ASII)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Percent Body Weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Female Sexual Desire Questionnaire (FSDQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: The Female Sexual Function Index (FSFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes